NONOF News and Press, Novo Nordisk - Class B

2026-03-12 06:54:05 ET Introduction Eli Lilly ( LLY ) has multiple catalysts ahead and is driving one of the major market themes outside of AI: weight loss and a broader trend toward healthier lifestyles. The upcoming Orforglipron launch, GLP-1 Medicare/Medicaid eligibility, and Lil...

2026-03-11 12:15:59 ET The Hims & Hers ( HIMS ) partnership with Novo Nordisk ( NVO ) could be the inflection point at which Hims evolves from being a controversial GLP-1 disruptor to being a legitimate consumer-focused healthcare platform. By aligning with the pharmaceu...

2026-03-11 10:40:53 ET Here on Seeking Alpha, I’ve made no secret of the fact that I’ve been a long-term Hims & Hers ( HIMS ) bull .... Read the full article on Seeking Alpha For further details see: This Novo Nordisk Partnership Shows That HIMS...

2026-03-11 09:47:27 ET Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 201...

2026-03-10 09:04:21 ET Investment Rating Update - "Buy" I updated my Buy rating on Novo Nordisk A/S ( NVO ) stock back in January, publishing a preview for the firm's Q4 print with a core thesis that a likely beat should have led to a strong post-earnings surge driven by dou...

2026-03-10 07:17:01 ET More on Eli Lilly CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade) Eli Lilly and Company (LLY) Presents at TD Cowen 46th Annual Health Care Co...

2026-03-09 14:47:08 ET Listen below or on the go on Apple Podcasts and Spotify Anthropic sues Pentagon after supply chain risk label kills AI contract. (0:15) Oil surge toward $120 sends VIX above 30 before retreat. (1:30) Hims and Hers jumps after partners...

2026-03-09 07:45:17 ET Hims & Hers ( HIMS ) has continued their sell-off after my latest article on the company in December 2025.... Read the full article on Seeking Alpha For further details see: Hims & Hers Health: The Potential Deal With Novo Nordisk I...

2026-03-07 09:20:50 ET More on Incyte, Novo Nordisk, etc. CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Pricing Pressure And Panic: What The Market May Be Missing In Novo Nordisk Incyte Corporation (INCY) Presents at TD Cowen 46...

2026-03-07 08:19:03 ET More on Hims & Hers Health, Novo Nordisk CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Hims & Hers Health: Leaving GLP-1s Behind Pricing Pressure And Panic: What The Market May Be Missing In Novo N...